Small Molecules Therapeutic Area

Australia is ideally positioned to be a major player in the global Pharma ecosystem where risk-averse companies are looking to in-licence assets that have demonstrated development potential.
Therefore, to enhance the progression of early stage discoveries through to preclinical development, TIA has formed a Small Molecules Group which is an integrated capability network of National Research Infrastructure across Australia. These facilities are committed to provide high quality research infrastructure to support leading‑edge research and to boost innovation in Australia.
Capabilities/Services offered  >

Compounds Australia

 
TIA-Logo_Darker-Blue.jpg

Pipeline Accelerator

Support for screening projects coming soon
Capabilities/Services offered  >

Australian Translational Medicinal Chemistry Facility 

ATMCF.jpg
Capabilities/Services offered  >

Centre for Drug Candidate Optimisation

cdco.jpeg
 
Capabilities/Services offered  >

Centre for Integrated Preclinical Drug Development

Capabilities/Services offered  >

TetraQ

TetraQ logo_b.jpg
 

Level 14, 330 Collins St

Melbourne 3000 VIC

Call

T: +61 (07) 3735 4433

©2019 Therapeutic Innovation Australia

Enabled by

NCRIS-PROVIDER-RGB-REV.png